Last updated: 2026-10-02 16:26:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Celularity Inc. (CELU) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1,59, with a market capitalisation of $43,81M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,56 to $2,55. This page covers its latest market performance, valuation, price trends and company information.
$43,81M | |
$1,37 | |
$134,00 | |
$0,56 | |
$1,38 | |
138,07K | |
3,96M | |
-- | |
$2,55 | |
$0,56 | |
-- | |
-- |
Celularity Inc. (CELU) is currently trading at $1,59 as of 2026-10-02 16:24:00, up 15,14% ($0,21) from the previous close of $1,38
During today's regular trading session, CELU has traded between $0,56 and $134,00, with a trading volume of 138,07K shares. The current price is near the lower end of today's range.
Over the past seven days, Celularity Inc. (CELU) moved from $1,15 to $1,59, representing a gain of 38,17% ($0,44).
The stock traded between $1,13 and $1,64 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 149,82 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 51,7%
CELU is currently trading at $1,59, placing it 51,7% of the way from its 52-week low of $0,56 to its 52-week high of $2,55. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 115 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Celularity Inc. (CELU) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.